Form D · Biotechnology
Attralus, Inc.
Burlingame, CA · CIK 0001797582
Offering snapshot reported Feb 9, 2024 · SEC filing
- Reported sold
- $56M Offering amount: $56M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $24.4K Reported outside-investor minimum
- First sale
- Jan 26, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 9, 2024 | Initial | $55,999,931 | No comparison | 12 | SEC filing |
| Sep 24, 2021 | Initial | $116,599,889 | No comparison | 22 | SEC filing |
| Dec 27, 2019 | Initial | $175,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-504871
Source: Form D, filed Feb 9, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jake Bauer | Director |
| Greg Bell | Executive |
| Gregory Bell | Executive |
| Alex Denner | Director |
| Glen Firestone | Executive |
| Benson Fong | Executive |
| Richard Gaster | Director |
| Corey Goodman | Director |
| Spencer Guthrie | Executive |
| Rahul Kakkar | Director |
| Mehdi Khodadad | Executive |
| Nancy Miller Rich | Director |
| James Testa | Executive |
| Mark Timney | Director, Executive |
| Jonathan Wall | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
337 C Beach Road
Burlingame, CA, 94010
Burlingame, CA, 94010